Accessibility Menu
Pharmadrug logo

Pharmadrug

(OTC) LMLLF

Current Price$0.01
Market Cap$724.80K
Since IPO (2018)-100%
5 Year-99%
1 Year+46%
1 Month-46%

Pharmadrug Financials at a Glance

Market Cap

$724.80K

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$470.38K

EPS (TTM)

-$0.00

P/E Ratio

-1.86

Dividend

$0.00

Beta (Volatility)

-0.82 (Low)

Price

$0.01

Volume

30,000

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

May 21, 2026

LMLLF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pharmadrug

Industry

Pharmaceuticals

CEO

Robert J. Steen, MBA

Headquarters

Toronto, ON M5K 1H1, CA

LMLLF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

19%

Return on Assets

-52%

Earnings Yield

-53.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$724.80K

Shares Outstanding

134.21M

Volume

30.00K

Avg. Volume

16.33K

Financials (TTM)

Gross Profit

-CA$50.20K

Operating Income

-CA$225.75K

EBITDA

-CA$175.55K

Operating Cash Flow

-CA$756.62K

Capital Expenditure

-CA$11.98K

Free Cash Flow

-CA$768.60K

Cash & ST Invst.

CA$23.22K

Total Debt

CA$1.52M

Pharmadrug Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$12.59K

N/A

Gross Margin

0.00%

N/A

Market Cap

$724.80K

N/A

Market Cap/Employee

$80.53K

N/A

Employees

9

N/A

Net Income

-CA$187.22K

-87.0%

EBITDA

-CA$34.51K

+33.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$388.71K

+419.9%

Total Debt

CA$1.61M

+17.0%

Accounts Receivable

CA$18.38K

+100.6%

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$1.61M

+17.0%

Return on Assets

-51.77%

N/A

Return on Invested Capital

19.10%

N/A

Free Cash Flow

-CA$64.19K

-576.7%

Operating Cash Flow

-CA$64.19K

-576.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UBQUUbiquitech Software Corp.
$0.00+0.00%
CPMDCannaPharmaRX, Inc.
$0.00-73.08%
RDDTFRadient Technologies Inc.
$0.00+0.00%
CNGGFCann Group Limited
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$160.95+0.19%
AALAmerican Airlines Group
$14.98+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%

Questions About LMLLF

What is the current price of Pharmadrug?

Pharmadrug is trading at $0.01 per share.

What is the 52-week range for Pharmadrug?

Over the past 52 weeks, Pharmadrug has traded between $0.00 and $0.02.

How much debt does Pharmadrug have?

As of the most recent reporting period, Pharmadrug reported total debt of CA$1.15M.

How much cash does Pharmadrug have on hand?

Pharmadrug reported CA$38.75K in cash and cash equivalents in its most recent financial results.

What is Pharmadrug’s dividend yield?

Pharmadrug does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.